Effect of 0.8mg/ml Losartan on Corneal Opacities

Abstract

Losartan, commonly used as an angiotensin receptor II inhibitor for hypertension, has recently revealed additional therapeutic properties. Studies demonstrate its potential in treating liver fibrosis, mitigating heart disease secondary to radiation, reducing skin scar formation, and even reversing renal cortical fibrosis. In a specific case, a female patient suffering from persistent bilateral nummular keratitis and corneal opacities experienced significant improvement in her left eye after using 0.8mg/ml Losartan eye drops. Untreated right eye showed no change. Based on the positive outcome, patient was offered same treatment in her right eye as well with monthly follow-ups, which she happily accepted. The stark contrast between the treated and untreated eye highlights the promising role of Losartan in treating corneal opacities.

doi: https://doi.org/10.12669/pjms.41.3.11237

How to cite this: Fawad A, Muzaffar W, Anjum U, Amer MN. Effect of 0.8mg/ml Losartan on Corneal Opacities. Pak J Med Sci. 2025;41(3):926-928.   doi: https://doi.org/10.12669/pjms.41.3.11237

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.